|
(R)-Omeprazole;Esomeprazole magnesium EP Impurity F
|
(R)-奥美拉唑
|
119141-89-8
|
|
γ-Secretase Inhibitor BZ
|
N-[(1S)-2-[[(3S)-2,3-二氢-1-甲基-2-氧代-5-苯基-1H-1,4-苯并二氮杂卓-3-基]氨基]-1-甲基-2-氧代乙基]-3,5-二氟苯乙酰胺
|
209986-17-4
|
|
γ-Secretase Inhibitor DAPT
|
DAPT
|
208255-80-5
|
|
γ-Secretase Inhibitor DBZ
|
二苯并氮卓
|
209984-56-5
|
|
Begacestat
|
BEGACESTAT
|
769169-27-9
|
|
BACE-1 inhibitor
|
BETA-SECRETASE INHIBITOR IV
|
797035-11-1
|
|
Moxifloxacin EP Impurity D;USP Moxifloxacin Related Compound D
|
莫西沙星杂质D(盐酸盐)
|
2252446-69-6
|
|
Ketoprofen EP Impurity I
|
3-苯甲酰苯基乙腈
|
21288-34-6
|
|
Ketoprofen EP Impurity J
|
酮洛芬EP杂质J
|
1785759-59-2
|
|
Phenacetin Impurity 25
|
非那西丁杂质25
|
856995-48-7
|
|
Sildenafil Impurity 74
|
西地那非杂质25
|
2021224-02-0
|
|
Enramycin
|
恩拉霉素
|
11115-82-5
|
|
Enramycin A
|
恩拉霉素A
|
34438-27-2
|
|
Enramycin B
|
恩拉霉素B
|
34304-21-7
|
|
Chloroatranol
|
氯化苔黑醛
|
57074-21-2
|
|
Roflumilast Impurity II
|
N-(3,5-二氯吡啶-4-基)-3-(环丙基甲氧基-4-羟基苯甲酰胺
|
1391052-76-8
|
|
Roflumilast Impurity IV
|
N-(3,5-二氯吡啶-4-基)-3,4-双二氟甲氧基苯甲酰胺
|
162401-30-1
|
|
Roflumilast Impurity V
|
罗氟司特杂质
|
475271-62-6
|
|
Rivaroxaban Impurity F
|
利伐沙班开环n-甲基杂质
|
1807455-76-0
|
|
Rivaroxaban Impurity I (Potential Impurity)
|
利伐沙班杂质G
|
721401-53-2
|
|
Rivaroxaban Impurity III (Potential Impurity)
|
利伐沙班杂质35
|
2206360-74-7
|
|
Edaravone P1 Impurity
|
依达拉奉P1杂质
|
1357477-99-6
|
|
Edaravone Trimer
|
依达拉奉三聚体杂质
|
124009-63-8
|
|
Ivabradine R-Isomer
|
伊伐布雷定杂质2
|
167072-91-5
|
|
Tadalafil EP Impurity F
|
他达拉非杂质06
|
2747958-44-5
|
|
Tadalafil EP Impurity G
|
他达拉非EP杂质G
|
2520114-46-7
|
|
Tadalafil EP Impurity H
|
他达拉非EP杂质H
|
1978322-98-3
|
|
Tadalafil Impurity K
|
他达那非杂质B
|
951661-82-8
|
|
Ticagrelor Impurity B (Ticagrelor Isomer 2)
|
替格瑞洛(替卡格雷)杂质2
|
2435586-30-2
|
|
Ticagrelor Impurity F(AZ13232789)
|
替格瑞洛杂质F
|
1616703-93-5
|
|
Ticagrelor Impurity M
|
替卡格雷杂质M
|
274693-39-9
|
|
Ticagrelor Related Compound I
|
替格瑞洛杂质38
|
2165881-71-8
|
|
Propofol Impurity M
|
2,6-二异丙基苯甲酸(丙泊酚杂质M)
|
92035-95-5
|
|
Moxifloxacin EP Impurity A;USP Moxifloxacin Related Compound A
|
8-氟莫西沙星
|
151213-15-9
|
|
Moxifloxacin EP Impurity B;USP Moxifloxacin Related Compound B
|
6,8-二甲氧基莫西沙星
|
1029364-73-5
|
|
Moxifloxacin EP Impurity C;USP Moxifloxacin Related Compound C
|
8-乙氧基莫西沙星
|
1029364-75-7
|
|
Moxifloxacin EP Impurity E;USP Moxifloxacin Related Compound E
|
8-羟基莫西沙星
|
721970-36-1
|
|
Moxifloxacin EP Impurity F (N-methyl Moxifloxacin)
|
盐酸莫西沙星杂质F
|
721970-37-2
|
|
(R,S)-Palonosetron HCl
|
RS-盐酸帕洛诺司琼
|
135755-51-0
|
|
Cilnidipine
|
西尼地平
|
132203-70-4
|
|
Hydroxychloroquine sulfate Impurity 14
|
羟氯喹杂质12盐酸盐
|
2411340-31-1
|
|
Palonosetron HCl
|
盐酸帕洛诺司琼
|
135729-62-3
|
|
Previtamin D(3)
|
3Β,6Z-9,10-断胆甾基-5(10),6,8-三烯甘油酯-3
|
1173-13-3
|
|
Famotidine EP Impurity A
|
法莫替丁相关化合物A盐酸盐
|
76833-47-1
|
|
Famotidine EP Impurity C
|
法莫替丁EP杂质C
|
106433-44-7
|
|
Famotidine EP Impurity J
|
法莫替丁EP杂质J盐酸盐
|
1798006-30-0
|
|
Pidotimod
|
匹多莫德
|
121808-62-6
|
|
Dabigatran Etexilate Impurity D
|
达比加群酯杂质P
|
2225986-95-6
|
|
Dabigatran Etexilate Impurity L
|
N-[[2-[[[4-(氨基亚氨甲基)苯基]氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]-N-(2-吡啶基)-BETA-丙氨酸乙酯盐酸盐
|
211914-50-0
|
|
Dabigatran Etexilate Impurity M
|
达比加群杂质O
|
948551-71-1
|
|
Dabigatran Etexilate Impurity O
|
达比加群杂质F
|
1642853-67-5
|
|
Dabigatran Etexilate Impurity P
|
3-[[[2-[[(4-氰基苯基)氨基]甲基]-1-甲基-1H-苯并咪唑-5-基]羰基]吡啶-2-基氨基]丙酸乙酯
|
211915-84-3
|
|
Dabigatran Etexilate Impurity Q
|
3-[(3-氨基-4-甲基氨基苯甲酰)吡啶-2-基氨基]丙酸乙酯
|
212322-56-0
|
|
Apixaban Impurity BMS-589154
|
1-(4-甲氧基苯基)-7-氧代-6-[4-(2-氧代哌啶-1-基)苯基]-4,5,6,7-四氢-1H-吡唑并[3,4-C]吡啶-3-羧酸乙酯
|
503614-91-3
|
|
Apremilast Impurity B (N-Deacetyl apremilast)
|
阿普司特N-脱乙酰基
|
635705-72-5
|
|
Apremilast Impurity C (Apremilast Dimer)
|
阿普斯特杂质03
|
1802246-60-1
|
|
Apremilast Impurity E
|
阿普斯特杂质19
|
2095036-40-9
|
|
Omeprazole Impurity J (H193/61)
|
埃索美拉唑进口标准杂质H193/61
|
784143-42-6
|
|
Omeprazole Impurity M
|
4-羟基奥美拉唑
|
301669-82-9
|
|
Thymosin alpha 1
|
醋酸胸腺α1
|
62304-98-7
|
|
Exenatide Acetate salt
|
醋酸艾塞那肽
|
141732-76-5
|
|
Terlipressin
|
特利加压素
|
14636-12-5
|
|
Parecoxib Sodium
|
帕瑞昔布钠
|
198470-85-8
|
|
Linagliptin Impurity J
|
利格列汀杂质A
|
2436762-89-7
|
|
Linagliptin Impurity L
|
利格列汀杂质D
|
666816-91-7
|
|
Linagliptin Impurity P
|
利格列汀杂质S
|
668273-74-3
|
|
Linagliptin Impurity R
|
利格列汀杂质H
|
1646355-34-1
|
|
Edoxaban Impurity B
|
依度沙班杂质F(单体)
|
480452-37-7
|
|
Edoxaban Impurity C
|
艾多沙班杂质1
|
2568974-02-5
|
|
Edoxaban Impurity F
|
依多沙班杂质41
|
480450-71-3
|
|
Edoxaban Impurity H
|
Edoxaban Impurity 29
|
2244103-96-4
|
|
Edoxaban Impurity I
|
依度沙班杂质9
|
2803372-49-6
|
|
Edoxaban Impurity O
|
2-((5-氯吡啶-2-基)氨基)-2-乙醛酸
|
552850-73-4
|
|
Edoxaban Impurity Q
|
依度沙班杂质 1
|
41374-72-5
|
|
Bacitracin A
|
杆菌肽 A
|
22601-59-8
|
|
Sitafloxacin
|
西他沙星
|
127254-12-0
|
|
Letrozole EP Impurity A
|
4,4'-(4H-1,2,4-三唑-4-基亚甲基)双苯腈
|
112809-52-6
|
|
Letrozole
|
来曲唑
|
112809-51-5
|
|
Bicalutamide EP Impurity A
|
二氟比鲁卡胺
|
90357-05-4
|
|
Bicalutamide EP Impurity B
|
2-氟-4-去氟比卡鲁胺
|
1159977-36-2
|
|
Bicalutamide EP Impurity C
|
双羟基比鲁卡胺
|
906008-94-4
|
|
Bicalutamide EP Impurity J
|
N-[4-氰基-3-(三氟甲基)苯基]-3-(4-氟苯巯基)-2-羟基-2-甲基丙酰胺
|
90356-78-8
|
|
Agomelatine
|
阿戈美拉汀
|
138112-76-2
|
|
Agomelatine Impurity A
|
阿戈美拉汀杂质醇
|
32820-10-3
|
|
Agomelatine Impurity D
|
7-甲氧基-1-萘酚
|
67247-13-6
|
|
Edoxaban Impurity A
|
依度沙班杂质D
|
480452-36-6
|
|
Famotidine EP Impurity H
|
(S)-((2-胍基-4-噻唑基)甲基)异硫脲二盐酸盐
|
88046-01-9
|
|
Dutasteride EP Impurity B
|
度他雄胺 EP 杂质 B
|
2512195-98-9
|
|
Tadalafil Impurity M
|
他达拉非杂质D
|
951661-81-7
|
|
Famotidine
|
法莫替丁
|
76824-35-6
|
|
Omeprazole
|
奥美拉唑
|
73590-58-6
|
|
Edoxaban
|
依度沙班
|
480449-70-5
|
|
Apremilast Impurity D
|
阿普斯特杂质19
|
2201974-01-6
|
|
Bacitracin B2
|
杆菌肽 B1A
|
57762-79-5
|
|
Bacitracin B1
|
杆菌肽B3
|
149146-32-7
|
|
Edoxaban Impurity D
|
依度沙班杂质11
|
2749802-54-6
|
|
Linagliptin Impurity T(Linagliptin Methyldimer)
|
LINAGLIPTIN METHYLDIMER
|
1418133-47-7
|
|
Flurbiprofen Impurity 92
|
氟比洛芬杂质03
|
1915720-16-9
|
|
Dabigatran Etexilate Impurity N
|
达比加群杂质E
|
1456889-80-7
|
|
Tadalafil EP Impurity I
|
他达拉非EP杂质I
|
2378614-29-8
|